![Patricia Grigoleit](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Patricia Grigoleit
Presidente en Ilya Pharma AB .
Perfil
Patricia Grigoleit is currently the Chairman at Ilya Pharma AB since 2021.
She previously worked as a Non-Executive Director at Fresenius Kabi Oncology Ltd.
and as an Executive VP-Active Pharmaceutical Ingredients at Fresenius Kabi AG.
She holds a doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main.
Cargos activos de Patricia Grigoleit
Empresas | Cargo | Inicio |
---|---|---|
Ilya Pharma AB
![]() Ilya Pharma AB BiotechnologyHealth Technology Ilya Pharma AB develops biological drugs for treating wounds in skin and mucosa. The company was incorporated in May 13, 2016 by Mia Johanna Phillipson, Stefan Roos and Evelina Wanda Matilda Vågesjö and is headquartered in Uppsala, Sweden. | Presidente | 01/01/2021 |
Antiguos cargos conocidos de Patricia Grigoleit.
Empresas | Cargo | Fin |
---|---|---|
Fresenius Kabi AG
![]() Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Corporate Officer/Principal | - |
FRESENIUS KABI ONCOLOGY LTD | Director/Miembro de la Junta | - |
Formación de Patricia Grigoleit.
Johann Wolfgang Goethe-Universität Frankfurt am Main | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Fresenius Kabi Oncology Ltd.
![]() Fresenius Kabi Oncology Ltd. Miscellaneous Commercial ServicesCommercial Services Fresenius Kabi Oncology Ltd. is a research and development company, which engages in manufacturing and development of oncology drugs. It also develops active pharmaceutical ingredients, intermediates and oral and injectable finished dosage forms. The company was founded on March 18, 2003 and is headquartered in Gurgaon, India. | Commercial Services |
Fresenius Kabi AG
![]() Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Health Technology |
Ilya Pharma AB
![]() Ilya Pharma AB BiotechnologyHealth Technology Ilya Pharma AB develops biological drugs for treating wounds in skin and mucosa. The company was incorporated in May 13, 2016 by Mia Johanna Phillipson, Stefan Roos and Evelina Wanda Matilda Vågesjö and is headquartered in Uppsala, Sweden. | Health Technology |
- Bolsa de valores
- Insiders
- Patricia Grigoleit